Diane E Bennett

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. pmc Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    PLoS ONE 4:e4724. 2009
  2. ncbi request reprint The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world
    Diane E Bennett
    Global AIDS Program, National Centre for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Curr Opin Infect Dis 19:607-14. 2006
  3. ncbi request reprint Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    Antivir Ther 13:25-36. 2008
  4. ncbi request reprint The World Health Organization's global strategy for prevention and assessment of HIV drug resistance
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    Antivir Ther 13:1-13. 2008
  5. pmc HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries
    Diane E Bennett
    US Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 54:S280-9. 2012
  6. pmc World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries
    Silvia Bertagnolio
    HIV Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 54:S254-60. 2012
  7. doi request reprint Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods
    Silvia Bertagnolio
    World Health Organization, Geneva, Switzerland
    Clin Infect Dis 54:S328-33. 2012
  8. pmc Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
    Jeffrey A Johnson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS Med 5:e158. 2008
  9. doi request reprint Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model
    Andrew N Phillips
    HIV Epidemiology and Biostatistics Group, Department of Primary Care and Population Sciences, and Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, University College London, London, UK
    Lancet 371:1443-51. 2008
  10. ncbi request reprint World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites
    Michael R Jordan
    Tufts University School of Medicine, Boston, MA, USA
    Antivir Ther 13:15-23. 2008

Collaborators

Detail Information

Publications16

  1. pmc Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    PLoS ONE 4:e4724. 2009
    ..The updated SDRM list has 93 mutations including 34 NRTI-resistance mutations at 15 RT positions, 19 NNRTI-resistance mutations at 10 RT positions, and 40 PI-resistance mutations at 18 protease positions...
  2. ncbi request reprint The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world
    Diane E Bennett
    Global AIDS Program, National Centre for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Curr Opin Infect Dis 19:607-14. 2006
    ..To describe surveillance measures to inform HIV drug-resistance prevention, as part of the public health approach to antiretroviral therapy in developing countries...
  3. ncbi request reprint Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    Antivir Ther 13:25-36. 2008
    ..Transmitted drug resistant HIV strains will be seen first in cities or health districts where antiretroviral treatment (ART) has been widely available for years. WHO recommends countries begin surveillance in these areas...
  4. ncbi request reprint The World Health Organization's global strategy for prevention and assessment of HIV drug resistance
    Diane E Bennett
    World Health Organization, Geneva, Switzerland
    Antivir Ther 13:1-13. 2008
    ..As of December 2007, 25 countries were planning or implementing the strategy; seven countries report results in this supplement...
  5. pmc HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries
    Diane E Bennett
    US Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Clin Infect Dis 54:S280-9. 2012
    ..EWIs measure these factors and the results have been used to optimize patient and population treatment outcomes...
  6. pmc World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries
    Silvia Bertagnolio
    HIV Department, World Health Organization, Geneva, Switzerland
    Clin Infect Dis 54:S254-60. 2012
    ....
  7. doi request reprint Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods
    Silvia Bertagnolio
    World Health Organization, Geneva, Switzerland
    Clin Infect Dis 54:S328-33. 2012
    ..Arm 2 yielded major advantages in cost and workload, with no evidence of increased sampling bias...
  8. pmc Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy
    Jeffrey A Johnson
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS Med 5:e158. 2008
    ..We used sensitive and simple tests to investigate evidence of transmitted drug resistance in antiretroviral drug-naïve persons and assess the clinical implications of minority drug-resistant variants...
  9. doi request reprint Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model
    Andrew N Phillips
    HIV Epidemiology and Biostatistics Group, Department of Primary Care and Population Sciences, and Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, University College London, London, UK
    Lancet 371:1443-51. 2008
    ..Our aim was to study the potential consequences of such monitoring strategies, especially in terms of survival and resistance development...
  10. ncbi request reprint World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites
    Michael R Jordan
    Tufts University School of Medicine, Boston, MA, USA
    Antivir Ther 13:15-23. 2008
    ..Performed regularly at representative sites, the data generated will inform evidence-based decision making regarding national and global ART regimen selection and minimize the emergence of HIVDR at a population level...
  11. ncbi request reprint Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania
    Geofrey R Somi
    National AIDS Control Program, Dar es Salaam, Tanzania
    Antivir Ther 13:77-82. 2008
    ..We used the WHO HIVDR threshold survey method to assess transmitted HIVDR in Dar es Salaam where ART was introduced in 1995 and where approximately 11,000 people are currently on ART...
  12. ncbi request reprint A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings
    Mark Myatt
    Division of Epidemiology, Institute of Ophthalmology, University College London, London EC1V 9EL, UK
    Antivir Ther 13:37-48. 2008
    ..The method is currently being used in several such settings...
  13. ncbi request reprint HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam
    HIEN TRAN NGUYEN
    National Institute for Hygiene and Epidemiology, Hanoi, Vietnam
    Antivir Ther 13:115-21. 2008
    ..Estimating transmitted resistance in the infected population will enable the appropriateness of current antiretroviral drug regimens to be assessed and will inform plans for future HIVDR surveillance...
  14. ncbi request reprint Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies
    Robert W Shafer
    Division of Infectious Diseases, Stanford University, Stanford, CA, USA
    Antivir Ther 13:59-68. 2008
    ..The process used to create a previously published list of drug resistance mutations for HIV-1 surveillance is reviewed and alternative approaches to this process are discussed...
  15. ncbi request reprint Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006
    Gugu Maphalala
    Swaziland Ministry of Health and Social Welfare, National Reference Laboratory, Mbabane, Swaziland
    Antivir Ther 13:95-100. 2008
    ..We used the WHO's HIVDR threshold survey method to assess transmitted HIVDR in three antenatal clinic (ANC) sites along the corridor between the two most populous cities in Swaziland, where ART was introduced in 2003...
  16. ncbi request reprint Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004
    Visva Pillay
    National Institute for Communicable Diseases, Johannesburg, South Africa
    Antivir Ther 13:101-7. 2008
    ....